Lifebit
Lifebit provides a federated Trusted Research Environment platform that enables secure, in-situ analysis of biomedical and genomic data without data movement, serving government health agencies, pharmaceutical companies, and research nonprofits across 30+ countries.
- Company typePrivate
- Founded2017
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Lifebit does
Lifebit is a London-based health data intelligence company that builds a federated Trusted Research Environment (TRE) platform enabling secure analysis of biomedical and genomic data without moving it from its source location. The platform brings compute to the data rather than centralizing data into a vendor cloud, enforcing GDPR, HIPAA, FedRAMP, ISO 27001, and SOC 2 compliance architecturally and supporting population-scale genomic research across sovereign jurisdictions. The modular product suite includes the core TRE, Trusted TargetID, Trusted Clinical Environment, Trusted Data Lakehouse, Trusted Data Factory, Trusted Data Hub, AI-Automated Airlock, Lifebit R.E.A.L. (pharmacovigilance), and the recently launched Version 4 Agentic Federated Platform, which enables researchers to perform the full research lifecycle through a natural language AI interface.
Lifebit serves government health agencies (Genomics England, NIH, Singapore MOH, CanPath), commercial pharmaceutical companies (Boehringer Ingelheim, Flatiron Health, 23andMe, United Health Group), and nonprofit research organizations (Lupus Research Alliance, Cancer Research Horizons). Named deployments collectively cover 275M+ patient records across 30+ countries, including 50 petabytes of Genomics England data, 100,000 Singaporean participants, and 5M+ Flatiron Health oncology records. Distribution occurs through direct enterprise sales, AWS Marketplace, and the UK Crown Commercial Services framework, with a free TRE START tier targeting small research teams.
The company operates a subscription-based licensing model with custom enterprise pricing, supported by an enterprise field sales motion targeting C-suite and research leadership. Lifebit has raised approximately $70.6M across seed through Series B rounds, with the September 2021 $60M Series B led by Tiger Global Management. The founding team includes CEO Maria Chatzou Dunford, CTO Pablo Barja, Chief Business Development Officer Thorben Seeger, and Chief Growth Officer Nate Raine. Lifebit is incorporated as Lifebit Biotech Limited in England and Wales, with US operations via Lifebit Biotech Inc. and an R&D centre in Singapore.
Lifebit firmographics
Firmographics- Name
- Lifebit
- Legal name
- Lifebit Biotech Limited
- Website
- https://lifebit.ai
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Lifebit provides a federated Trusted Research Environment platform that enables secure, in-situ analysis of biomedical and genomic data without data movement, serving government health agencies, pharmaceutical companies, and research nonprofits across 30+ countries.
- Ownership category
- akta.pro rank
Lifebit industry classification
Industry- Product category
- Biomedical Data Analytics Software
- NAICS
- Software Publishers (5132), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Cloud Security (CSPM/CWPP/CIEM) for Health IT (HLACAJAG)
Keywords
Where Lifebit is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Lifebit business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Platform Subscription and Licensing: Lifebit generates revenue primarily through subscription-based licensing of its federated Trusted Research Environment platform. The platform is deployed within customers' own cloud environments (not Lifebit's), with customers paying for access to the analytics infrastructure, security features, and governance tools. Pricing includes tiered plans with a free tier (TRE START) for small research teams and non-profits, as well as paid enterprise plans. Revenue is recurring in nature as customers maintain ongoing subscriptions for platform access and support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | TRE START - Free tier for small research teams and non-profits |
| Subscription | Annual | Enterprise paid plans for government, pharma, and healthcare organizations |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
Lifebit product offering
Product offeringCore offering
Lifebit builds and licenses a federated Trusted Research Environment (TRE) platform (CloudOS) that enables secure, in-situ analysis of distributed biomedical and genomic data without moving it from source locations. The platform is deployed inside customers' own cloud environments and is sold via enterprise subscription, with a free TRE START tier, and includes modular components for target identification, clinical interpretation, data harmonization, federated querying, security/governance, and adverse drug reaction surveillance.
Product overview
Lifebit offers a federated Trusted Research Environment (TRE) platform with a modular architecture designed for secure, in-situ analysis of distributed biomedical data without data movement. The core platform comprises the Trusted Research Environment as the primary product, supplemented by specialized modules including Trusted TargetID (drug target identification), Trusted Clinical Environment (clinical analysis), Trusted Data Lakehouse (data cataloging), Trusted Data Factory (OMOP mapping/harmonization), Trusted Data Hub (federated querying), Trusted Data Marketplace (access to 275M+ patient records), and Lifebit R.E.A.L. (adverse drug reaction surveillance). Security and governance modules include Airlock/AI-Automated Airlock (data export controls), Security Posture Management, System Health Observability, Security Tower, and Trusted Operational Governance. The Agentic Federated Platform (Version 4) represents the latest major release, introducing conversational AI capabilities. TRE START provides a free tier for small teams, while Rapid Data Products enables instant access to curated datasets.
Differentiator
Problem solved
Functional benefit
Products and services
- Trusted Research Environment (TRE) The world's #1 federated Trusted Research Environment enabling secure, in-situ analysis of distributed biomedical data without data movement, supporting population-scale genomics and health data research across sovereign jurisdictions. For government, pharma, health nonprofit, and health system customers.
- Trusted TargetID AI-powered drug target identification and validation module within the TRE, enabling researchers to turn biomedical data into validated drug targets through federated analysis. For pharmaceutical R&D and translational informatics teams.
- Trusted Clinical Environment Specialized TRE for clinical data analysis, turning data into clinical actions and supporting clinical interpretation and healthcare decision-making. For health systems and clinical research teams.
- Lifebit R.E.A.L. Real-time drug side effects and disease outbreak surveillance platform for pharmacovigilance and public health monitoring. For pharma, public health agencies, and government health bodies.
- Trusted Data Lakehouse Federated data automation module for connecting and cataloging distributed biomedical data assets at scale, providing data infrastructure for health and genomic data management. For pharma, government, and data provider customers.
- Trusted Data Factory AI-powered data transformation and harmonization tool that maps distributed data to OMOP and other standards, making data usable for federated analysis. For enterprise research data teams and government health agencies.
- AI-Automated Airlock AI-powered governance solution for secure biomedical data exports with real-time RAG risk decisioning and governed workflows, automating compliance without manual review. Trusted by institutions managing over 275 million patient records. Available via AWS Marketplace for cloud-native procurement.
- Trusted Data Marketplace Data marketplace providing access to federated patient data from 275M+ patients across 30+ countries for research and drug discovery. For pharmaceutical and biotech customers seeking cohort access.
- Rapid Data Products Instant access to deeply curated, multimodal real-world data for medical research, allowing teams to quickly browse, select, and analyze disease cohorts across therapeutic areas including Cardiometabolic, CNS, and Inflammatory. For pharma R&D teams.
- Agentic Federated Platform (Version 4) Version 4 of Lifebit's platform, claimed as the world's first fully agentic Trusted Research Environment, enabling researchers to perform the entire research lifecycle from data harmonization to results interpretation through a conversational natural-language AI interface. For enterprise research teams and government agencies.
- TRE START Free tier of the Trusted Research Environment allowing small research teams and non-profits to deploy secure, compliant research environments directly in their cloud accounts with rapid setup and integration. For small research teams, academic labs, and budget-constrained non-profits.
- Trusted Operational Governance Comprehensive governance solution providing role-based access, policy enforcement, and complete audit trails for every action, user, and system across federated environments. For enterprise compliance, security, and IT teams.
Quantifiable outcome
- 90% faster target identification and validation for pharmaceutical companies
- +7 more outcomes
Companies that use Lifebit
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles5 records
Lifebit technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability8 records
Feature14 records
Lifebit partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core, minor and flagship.
- Lung Cancer Genetics StudycoreLung Cancer Genetics Study launched by 23andMe, Troper Wojcicki Philanthropies, and Lifebit. Open-source data platform provides researchers access to de-identified genetic and health data for lung cancer research. Study has enrolled 1,200+ participants targeting 10,000 by 2027.
- 23andMecorePartnership for the Lung Cancer Genetics Study open-source data platform, launched by 23andMe Research Institute, Troper Wojcicki Philanthropies, and Lifebit. Lifebit's TRE enables qualified researchers to access de-identified genetic and health data at no cost.
- Troper Wojcicki PhilanthropiesminorFunding partner for the Lung Cancer Genetics Study, collaborating with 23andMe and Lifebit to advance lung cancer genetics research with an open-source data platform.
- Cancer Research HorizonscorePartnership to maximise the impact of research data through federated analysis capabilities, enabling Cancer Research Horizons to leverage Lifebit's secure research environment.
- PsifasminorPartnership to advance genomic research in Israel through Lifebit's federated platform capabilities.
- Flatiron HealthcoreMulti-year strategic partnership announced May 31, 2023 to support vital cancer research enabling scientific discoveries. Lifebit's federated TRE enables approved researchers to safely access Flatiron's high-quality real-world oncology data for breakthrough analysis globally. Flatiron has international presence across UK, Germany, US and Japan.
- Lupus Research AlliancecoreLupus Research Alliance's DREAM platform runs on Lifebit's federated TRE, uniting molecular and clinico-phenotypic data across 9+ CROs in US and Canada for lupus research without data movement.
- Genomics EnglandflagshipGenomics England Research Environment powered by Lifebit's federated TRE, supporting the 100,000 Genomes Project, National Genomic Research Library, and Generation Study with 5,000+ researchers.
- NIH / NLMflagshipFirst federated platform deployed at NIH, connecting 8 Institutes/Centers with 19 pan-IC datasets mapped to OMOP CDM for unified, federated discovery across NIH research assets.
- Synapxe (Singapore)flagshipCollaboration with Singapore's national HealthTech agency for the TRUST platform (Singapore's Trusted Research and Real-World Data Discovery Platform). Lifebit opened an R&D centre in Singapore to support this national initiative.
- CanPath / Genome CanadacoreCanPath's 350,000-participant dataset accessible through Lifebit's federated TRE with pan-Canadian regulatory compliance across diverse provincial requirements.
- Boehringer IngelheimcoreAnalytics platform deployed inside Boehringer Ingelheim's own cloud environment for translational research, enabling federated analysis across UK Biobank, Genomics England, and internal clinical data. Partnership includes outbreak detection on real-world data using Lifebit R.E.A.L.
- Flatiron HealthcorePartnership to advance cancer care in Japan through real-world data analysis using Lifebit's federated platform.
- AWS MarketplacecoreAI-Automated Airlock product available for rapid procurement via AWS Marketplace, enabling cloud-native customers to deploy compliant data export controls at scale.
- SynapxeflagshipR&D centre opened in Singapore in collaboration with Synapxe to support Singapore's National Precision Medicine programme and TRUST platform operations.
Scale indicators15 records
Recent moves7 records
Expansion highlights6 records
Lifebit competitors and assessment
Company assessmentDirect peers
- DNAnexus: DNAnexus provides a cloud-based biomedical informatics platform for genomics and clinical data, directly competing with Lifebit's Trusted Research Environment in pharma, government, and diagnostics use cases. Both target federated analysis of large-scale genomic and clinical data.
- BC Platforms: BC Platforms offers a genomic data platform with federated access to biobanks and real-world data for pharma R&D, overlapping directly with Lifebit's Trusted Data Marketplace and TRE capabilities across European and global pharma customers.
- Velsera (formerly Seven Bridges): Velsera provides a genomics and multi-omics data analysis platform serving pharma, academic, and clinical customers, directly competing with Lifebit on cloud-based biomedical analysis, federated workflows, and clinical interpretation tools.
- Datavant: Datavant specializes in health data connectivity, de-identification, and privacy-preserving record linkage, addressing the same federated, secure data-sharing problems Lifebit solves for biomedical research, with overlap in life sciences and government health customers.
Broad incumbents
- Palantir Foundry: Palantir's Foundry platform is used by major government health agencies and large pharma companies for data integration and analytics. While broader in scope, it competes with Lifebit for the same institutional budgets around health data integration and analytics.
- Verily (Alphabet): Verily operates a broad health data platform spanning real-world evidence, clinical research, and precision medicine, overlapping with Lifebit in pharma R&D and national health initiatives. It benefits from Alphabet-scale infrastructure and competes for similar large customer budgets.
- IQVIA (E360 / Orchestrated Patient Insights): IQVIA is a dominant clinical and real-world data provider with a healthcare analytics platform serving pharma. It is a broad incumbent competing for the same pharma R&D and health system analytics budgets that Lifebit addresses with its federated TRE.
Emerging players
- Owkin: Owkin applies federated AI to biomedical research, particularly in oncology, directly overlapping with Lifebit's federated learning and pharma R&D positioning. Both target pharma customers seeking privacy-preserving access to distributed hospital data.
- Seqera Labs: Seqera provides Nextflow-based workflow orchestration widely used in genomics and life sciences research, with overlap in cloud-based scientific data analysis. While more focused on workflow orchestration than full TRE, Seqera is increasingly used in similar biomedical research pipelines.
- TripleBlind: TripleBlind provides privacy-preserving computation APIs for healthcare and life sciences, addressing similar federated data access problems as Lifebit, though at an earlier stage and with a more API-oriented product rather than a full TRE.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lifebit social profiles
Digital presenceLifebit compliance and trust
Trust signalCompliance8 records
Lifebit financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lifebit leadership team
Management profileNumber of profiles
Profiles7 records
Lifebit funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lifebit M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lifebit
What does Lifebit do?
Lifebit builds and licenses a federated Trusted Research Environment (TRE) platform (CloudOS) that enables secure, in-situ analysis of distributed biomedical and genomic data without moving it from source locations. The platform is deployed inside customers' own cloud environments and is sold via enterprise subscription, with a free TRE START tier, and includes modular components for target identification, clinical interpretation, data harmonization, federated querying, security/governance, and adverse drug reaction surveillance.
Is Lifebit a public or private company?
Lifebit is a private company. It is classified as venture growth investor backed and is currently operating.
When was Lifebit founded?
Lifebit was founded in 2017. It employs 51 to 100 people.
Where is Lifebit based?
Lifebit is headquartered in London, United Kingdom, in the Europe region.
How does Lifebit make money?
One revenue line is on record: platform Subscription and Licensing.
Who are Lifebit's main competitors?
Direct peers on record are DNAnexus, BC Platforms, Velsera (formerly Seven Bridges) and Datavant. Broad incumbents are Palantir Foundry, Verily (Alphabet) and IQVIA (E360 / Orchestrated Patient Insights). Emerging players are Owkin, Seqera Labs and TripleBlind.
Does Lifebit have an API?
No public API is recorded for Lifebit.
What industry is Lifebit in?
Lifebit's product category is Biomedical Data Analytics Software. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5132 and its SIC code is 7372.